
Glimfirst-MP 1 Tablet SR
Marketer
Sinsan Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimfirst-MP 1 Tablet SR
Glycemicontrol-XR, a single-strength tablet, combines medications to effectively manage blood glucose. In adults with type 2 diabetes, it complements diet and exercise to enhance glycemic control. This medication promotes efficient insulin use, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen. To prevent digestive discomfort, take with food. If a dose is missed, take it promptly; however, near the next scheduled dose, omit the missed one and resume your usual schedule. Never double the dose; an overdose risks dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function tests will be evaluated before treatment begins. Limit alcohol consumption during treatment, as this can heighten the chance of adverse reactions.
Uses of Glimfirst-MP 1 Tablet SR
Managing Type 2 diabetes
Major Benefits of Glimfirst-MP 1 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glimfirst-MP 1 Tablet SR with a meal.
Common Side effects of Glimfirst-MP 1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimfirst-MP 1 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Glimfirst-MP 1 Tablet SR with a meal.
How Glimfirst-MP 1 Tablet SR works:
Glimfirst-MP 1 Tablet SR combines the actions of three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. This triple-drug approach enhances blood sugar management when single or dual-agent therapies prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimfirst-MP 1 Tablet SR and alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimfirst-MP 1 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to any prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimfirst-MP tablet (1mg) should likely be avoided while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Glimfirst-MP 1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimfirst-MP 1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Exercise caution when prescribing Glimfirst-MP 1 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. Glimfirst-MP 1 Tablet SR is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Glimfirst-MP 1 Tablet SR :
Should you forget a dose of your Glimfirst-MP 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glimfirst-MP 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
